Résultats de la recherche - 28 results

Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries

populations ≥50 years of age, living in the community, in six European countries: Belgium, Denmark, Luxembourg, Navarre (Spain), Norway, and Portugal. This study was undertaken within the Vaccine Effectiveness ...

Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)

February 16, 2022) . From May 2022, Flanders offered a second booster vaccination to nursing home (NH) residents and people aged over 80 years. In early July 2022, a second booster vaccination was offered to ...

Epidemiology of COVID-19 mortality in Belgium from wave 1 to wave 7 (March 2020 – 11 September 2022)

week 15 2020). Age and sex 91.8% of the COVID-19 deaths were 65 years and older. The median age of COVID-19 deaths was 84 years old and the average age was 81.6 years old. In all age groups up to 80-84 ...

Epidémiologie de la mortalité COVID-19 en Belgique de la vague 1 à la vague 7 (mars 2020- 11 septembre 2022)

hebdomadaires dus à la           COVID-19 a été observé au cours de la vague 1 (1 985 décès au cours de la semaine 15, 2020). Age et sexe 91,8 % des personnes décédées à cause de la COVID-19 avaient 65 ans ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)

study population, older age was associated with a higher risk of not having antibodies in wave 2. Among the fully vaccinated, older people and people with at least one chronic disease were at higher risk ...

Atlas of cause-specific all-ages mortality by district in Belgium, 2010- 2017

Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Aline Scohy; Françoise Renard; Jure Jurcevic Source: Sciensano, Brussels, p.22 (2021) Health Topics:  Life expectancy Espérance de vie Levensverwachting Service:  In ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study

community dwelling population aged 18 years and above had developed anti- SARS-CoV-2 antibodies. This percentage was 98.9% among fully vaccinated people (since at least 2 weeks before being tested) and 28.9% ...

Surveillance van COVID-19 gerelateerde mortaliteit in België, epidemiologie en methodologie tijdens 1e en 2e golf (maart 2020- 14 februari 2021)

leeftijdsstandaardisatie (age-standardized mortality rate, ASMR), die rekening houden met de leeftijdsverdeling van de bevolking, toonden aan dat Brussel de hoogste ASMR vertoonde voor de totale periode en de eerste golf, ...

Surveillance de la mortalité COVID-19 en Belgique, épidémiologie et méthodologie durant la 1re et 2e vague (mars 2020- 14 février 2021)

la seconde). Les taux de mortalité COVID-19 standardisés pour l’âge (age-standardized mortality rate, ou ASMR) qui tiennent compte de la répartition par âge de la population, montrent que Bruxelles ...

Surveillance of COVID-19 mortality in Belgium, epidemiology and methodology during 1st and 2nd wave (March 2020- 14 February 2021)

retrograde adaptations of mortality numbers. The overall sex distribution was fairly even (49.1% in male and 50.8% in female). Almost all deaths occurred in the age group over 64 years and approximately half ...

QR code

QR code for this page URL